Selected Publications

Marchetti B, Ashrafi GH, Tsirimonaki E, O'Brien PM and Campo MS. The papillomavirus oncoprotein E5 retains the major histocompatibility class I in the Golgi apparatus and prevents its transport to the cell surface. Oncogene 2002; 21: 7808-7816.

Ashrafi GH, Haghshenas MR, Marchetti B, O'Brien PM and Campo MS. The E5 protein of human papillomavirus type 16 selectively down-regulates surface HLA class I. Int J Cancer 2005; 113: 276-283.

Beniston RG and Campo MS. HPV-18 transformed cells fail to arrest in G1 in response to quercetin treatment. Virus Research 2005; 109: 203-209.

Marchetti B, Ashrafi GH, Dornan E, Araibi EH, Ellis SA and Campo MS. The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus. Oncogene 2006; 27: 2254-2263.

Ashrafi GH, Brown D, Fife KH and Campo MS. Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. Virus Res 2006; 120: 208-211.

Ashrafi GH, Haghshenas M, Marchetti B and Campo MS. E5 protein of Human Papillomavirus 16 down-regulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int. J. Cancer 2006; 119: 2105-2112.

Araibi EH, Marchetti B, Dornan ES, Ashrafi GH, Dobromylskyj M, Ellis SA and Campo MS. The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I. Virology 2006; 353: 174-183.

Campo MS (editor). Papillomavirus: from Natural History to Vaccines and Beyond, 2006. Publishers Horizon Scientific Press, UK.